China SXT Pharmaceuticals, Inc. (SXTC) Total liabilities 2018–2026
China SXT Pharmaceuticals, Inc. (SXTC) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2026 · since FY2018: $4.4M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $5.0M | -18.9% |
| FY2025 | $6.2M | -32.3% |
| FY2024 | $9.2M | -38.1% |
| FY2023 | $14.9M | -13.2% |
| FY2022 | $17.1M | -7.9% |
| FY2021 | $18.6M | +51.1% |
| FY2020 | $12.3M | +93.3% |
| FY2019 | $6.4M | +45.5% |
| FY2018 | $4.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice